More good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%,...

|About: Synovis Life Technologies, ... (SYNO)|By:, SA News Editor

More good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%, continuing the medical device company's streak of double-digit sales growth. Sales of its Peri-Strips for gastric bypass surgery, the biggest contributor to its top line, climbed 28%. Yesterday, SYNO agreed to be acquired by Baxter (BAX) for $28/share.